Stay updated on Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.

Latest updates to the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page
- CheckyesterdayChange DetectedThe page footer’s software/site revision label is updated from v3.5.2 to v3.5.3, reflecting a backend or display release rather than an update to the ClinicalTrials.gov study information.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedWebsite version updated from v3.4.3 to v3.5.0. No study content or user-facing details were altered.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This appears to be a minor site update with no changes to study content.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated: v3.4.2 added; v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no substantive changes to study details or page interactions are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.